Loading provider…
Loading provider…
Transplant Surgery Physician in Los Angeles, CA
NPI: 1407839681Primary Employer
USC Care Medical Group, Inc
keckmedicine.org
HQ Phone
Get MD Myron's Phone NumberMobile
Get MD Myron's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1967 - 2025

American Board of Internal Medicine
Internal Medicine
UCSF School of Medicine
medschool.ucsf.edu
Medical School
Until 1966
University of Southern California/Los Angeles General Medical Center (USC/LA General)
Residency • Internal Medicine
1971 - 1974
Internship • Internal Medicine
1966 - 1967
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 270 | 544 |
| 2 | 91200Measurement of liver stiffness | 29 | 32 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 12 | 12 |
| 4 | 99443Physician telephone patient service, 21-30 minutes of medical discussion | 12 | 14 |
Integrating recent data in managing adverse events in the treatment of hepatocellular carcinoma.
Authors: Robert Gish, Ghassan Abou-Alfa
Journal: Gastroenterol Hepatol (N Y)
Long‐term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen–positive chronic hepatitis B
Authors: Patrick Marcellin, Ting-Tsung Chang, Seng G Lee Lim, William Sievert, Myron J. Tong, Sarah Arterburn, Katyna Borroto-Esoda, David W. Frederick, Franck Rousseau
Publication Date: 2008-09
Lead Sponsor: Gilead Sciences
Intervention / Treatment: DRUG: Tenofovir disoproxil fumarate (TDF), DRUG: GS-4774, DRUG: GS-9620
Lead Sponsor: Huntington Medical Research Institutes
Collaborators: GlaxoSmithKline
Intervention / Treatment: DRUG: placebo control, DRUG: Lovaza
Lead Sponsor: Huntington Medical Research Institutes
Collaborators: InterMune
Intervention / Treatment: DRUG: IFN-γ 1b and Adefovir dipivoxil combination, DRUG: Adefovir dipivoxil, DRUG: IFN-γ 1b (Actimmune)